Replies to post #8382 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>…we will still need more financing to avoid a "going concern" from the auditors.<

Auditors typically consider issuing such a qualification only once per year, when auditing the books at the end of the fiscal year. Hence there is no need to worry about such a qualification until the 2008 10K is prepared in early 2009. By then, I expect that GTC’s financial position will be better than it is now.

[DewDiligence]

>Wasn't this only 5.5?<

Correct. The net proceeds from the offering were $5.5M.

[jessellivermore]

Sorry./// you are right bout the 5.5 million, I forgot they were not getting a dollar a share. I think the rest is pretty close to their estimate. My main point is I think their financial situation is much better than Wall Street is giving them credit for, and the DIC program looks very good and will add a number of options.... Nobody ever confused me with an accountant.